Generic Depakote wins FDA approval

A generic version of Depakote, an anti-seizure medication that clinicians also use to treat migraine headaches and bipolar disorder, received FDA approval yesterday. Abbott Laboratories originally manufactured the drug.

The approval was for delayed-release tablets and will have the same black box warning that the branded drug has, which includes warnings about liver and pancreas risks, as well as the risk of birth defects. 

Eight different companies received licensure to begin marketing the drug, including Sun Pharmaceuticals and Teva Pharmaceuticals.

- here's the FDA release
- read the story at WebMD
- see more from the Washington Post

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.